---
type: "Nootropic"
title: "St. John's wort"
description: "What is St. John's Wort? Hypericin and hyperforin mechanisms, effects on depression, drug interactions and dosage. Comprehensive guide."
resource: "https://nootropikler.com/nootropics/st-johns-wort"
tags: ["depression", "anxiety", "Mood"]
timestamp: 2026-11-11T00:00:00Z
category: "Mood"
source: "Natural"
latin: "Hypericum perforatum"
language: "en"
---

# St. John's wort

*Hypericum perforatum*

The Linde et al. (2008) Cochrane review included 29 trials and 5489 patients. Tested St John’s wort extracts outperformed placebo and had similar outcomes to antidepressants; findings cannot automatically generalize to all products, depression severities or individual treatment.

## Quick profile

| Property | Value |
| --- | --- |
| Onset of Effect | No established timeframe |
| Half life | Depends on the constituent and extract |
| Dose used in research | Varies by extract and study |
| Safety | See detailed safety warnings |
| Level of Evidence | Depends on the extract and depression severity |

> Correction · 2026-11-11: The single dose range and half-life were removed. The tested extracts and drug interactions are now identified.

> **⚠ Drug Interaction Warning:** St John’s wort can reduce levels of some medicines through effects on drug-metabolizing enzymes and P-glycoprotein; examples include birth control pills, cyclosporine, warfarin, digoxin and some HIV medicines. Combining it with antidepressants also risks serious serotonergic adverse effects. Interactions do not all arise from CYP3A4 alone; starting or stopping use requires discussion with a clinician/pharmacist.

## What is St. John's Wort?

St. John's wort (*Hypericum perforatum*) is a perennial plant belonging to the family of flowering plants. Native to Europe, Asia and North Africa, this plant has been used in traditional folk medicine for centuries for depression, anxiety, wound healing and nerve pain. It is known as St. John's wort or binbirdelik herb in Türkiye.

Extracts vary in hypericin and hyperforin content. A percentage or extract ratio alone does not prove efficacy, safety or equivalence to a trial product; no single percentage is a universal product recommendation.

## Mechanism of Effect

St John’s wort extracts contain multiple compounds; laboratory effects on neurotransmitter systems do not establish which mechanism produces clinical benefit in humans. An isolated compound does not justify labeling an extract “SSRI-like,” an MAO inhibitor or anxiolytic. Clinical trials assess specific extracts; products are not all equivalent.

## Clinical Evidence

The Linde et al. (2008) Cochrane review included 29 trials and 5489 patients. Tested St John’s wort extracts outperformed placebo and had similar outcomes to antidepressants; findings cannot automatically generalize to all products, depression severities or individual treatment.

In a NIH-funded 2002 trial, 340 adults received St John’s wort, sertraline or placebo for 8 weeks. Neither active treatment significantly beat placebo on the two primary outcomes; one trial cannot conclusively settle all treatment of severe depression.

## Dose information and research limits

> **Dose information and research limits:** This dose information describes research or product context; it is not a personal prescription, established safe upper limit or efficacy guarantee for healthy people. Extracts and different formulations should not be treated as equivalent milligram for milligram.

## Safety and Drug Interactions

St John’s wort may worsen symptoms with bipolar disorder or a history of psychosis. Serotonin-syndrome risk with antidepressants and reduced efficacy of many medicines make self-treatment inappropriate. Pregnancy and breastfeeding safety is not adequately established.

- **SSRI and antidepressants:** Risk of serotonin syndrome (serious, should not be combined)

- **Birth control pills:** Hormonal contraception failure

- **Warfarin:** Decreased anticoagulant effect, risk of thrombosis

- **Cyclosporine:** Risk of organ transplant rejection

- **HIV antiretrovirals, digoxin:** Loss of drug effectiveness

- Increased sensitivity to sunlight (due to hypericin, especially in people with fair skin)


## Frequently Asked Questions

### What is St. John's Wort used for?

The Linde et al. (2008) Cochrane review included 29 trials and 5489 patients. Tested St John’s wort extracts outperformed placebo and had similar outcomes to antidepressants; findings cannot automatically generalize to all products, depression severities or individual treatment.

### Can St. John's wort be used with medications?

St John’s wort can reduce levels of some medicines through effects on drug-metabolizing enzymes and P-glycoprotein; examples include birth control pills, cyclosporine, warfarin, digoxin and some HIV medicines. Combining it with antidepressants also risks serious serotonergic adverse effects. Interactions do not all arise from CYP3A4 alone; starting or stopping use requires discussion with a clinician/pharmacist.

### Is St. John's wort good for severe depression?

The Linde et al. (2008) Cochrane review included 29 trials and 5489 patients. Tested St John’s wort extracts outperformed placebo and had similar outcomes to antidepressants; findings cannot automatically generalize to all products, depression severities or individual treatment.

### Can St. John's wort be found in Türkiye?

Sale and import status in Türkiye must be checked for the specific product. Verify supplement approval in the Ministry of Agriculture and Forestry GGBS list, and medicine authorization and conditions of use in TİTCK records. Online availability does not establish approval or unrestricted personal import; current Ministry of Trade conditions apply to postal and express shipments.

## Sources

- Linde K, et al. (2008). St John's wort for major depression. *Cochrane Database of Systematic Reviews*. [PubMed · PMID 18843608](https://pubmed.ncbi.nlm.nih.gov/18843608/)
- Hypericum Depression Trial Study Group. (2002). Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial. *JAMA*, 287(14), 1807–1814. [PubMed · PMID 11939866](https://pubmed.ncbi.nlm.nih.gov/11939866/)
- Müller WE. (2003). Current St. John's Wort research from mode of action to clinical efficacy. *Pharmacological Research*, 47(2), 101–109. [PubMed · PMID 12543057](https://pubmed.ncbi.nlm.nih.gov/12543057/)
- Borrelli F, Izzo AA. (2009). Herb-drug interactions with St John's wort (Hypericum perforatum): an update on clinical observations. *AAPS Journal*, 11(4), 710–727. [PubMed · PMID 19859815](https://pubmed.ncbi.nlm.nih.gov/19859815/)
- National Center for Complementary and Integrative Health. St. John’s Wort: Usefulness and Safety. https://www.nccih.nih.gov/health/st-johns-wort [NIH NCCIH](https://www.nccih.nih.gov/health/st-johns-wort)

## Related nootropics

- [5-HTP](/okf/nootropics/5-htp.md)
- [Saffron Extract](/okf/nootropics/saffron.md)
- [ashwagandha](/okf/nootropics/ashwagandha.md)
